FIGURE 4
BAI decreases the serum level of TNF-α and increases IL-10 level in MRSA-challenged mice. C57BL/6J mice were intraperitoneally infected with MRSA (2 × 108 CFU/mouse) and treated with BAI (100 mg/kg), DXM (7 mg/kg), and VAN (110 mg/kg). Blood samples were collected, clotted, and centrifuged at 4°C (3500 rpm, 25 min) to obtain serum samples after 12 h. The serum levels of IL-6 (A), TNF-α (B), IL-12p70 (C), MCP-1 (D), IFN-γ (E), and IL-10 (F) were measured by cytometric bead array (CBA) assay. Data were expressed as mean ± sd (N = 5/group). Statistical significance was determined at *P < 0.05; **P < 0.01; and ***P < 0.001

BAI decreases the serum level of TNF-α and increases IL-10 level in MRSA-challenged mice. C57BL/6J mice were intraperitoneally infected with MRSA (2 × 108 CFU/mouse) and treated with BAI (100 mg/kg), DXM (7 mg/kg), and VAN (110 mg/kg). Blood samples were collected, clotted, and centrifuged at 4°C (3500 rpm, 25 min) to obtain serum samples after 12 h. The serum levels of IL-6 (A), TNF-α (B), IL-12p70 (C), MCP-1 (D), IFN-γ (E), and IL-10 (F) were measured by cytometric bead array (CBA) assay. Data were expressed as mean ± sd (N = 5/group). Statistical significance was determined at *P < 0.05; **P < 0.01; and ***P < 0.001

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close